372 results
8-K
jfalpckew2
7 Mar 12
Discovery Labs Announces FDA Approval of SURFAXIN® (lucinactant) for Prevention of Respiratory Distress Syndrome
12:00am
8-K
gwx7v
15 Apr 13
Other Events
12:00am
8-K
dd91m hy2ccn
24 Oct 12
Other Events
12:00am
8-K
giam1mcu 85ts
22 Jun 06
Discovery Labs Retains Jefferies & Company to Assist in the Evaluation of Potential Strategic Alternatives
12:00am
8-K
yoynybb
7 Jun 06
Other Events
12:00am
8-K
zub1az1
4 Oct 13
Discovery Labs Announces FDA Approval of SURFAXIN® (lucinactant) Updated Product Specifications
12:00am
8-K
657fokjf6vca4x
12 May 09
Other Events
12:00am
8-K
ijlhw0e 2rls4
2 Nov 07
Discovery Labs Submits Response to FDA Approvable Letter for SurfaxinÒ for RDS in Premature Infants
12:00am
8-K
a2dt4fmeb984a ggf
28 Apr 10
Discovery Labs Provides Updates on Surfaxin®, Other Key Programs and First Quarter 2010 Financial Results
12:00am
8-K
hwat 9t9s7hri6n
1 Aug 05
Discovery Labs Submits Response to FDA Approvable Letter for SurfaxinÒ for RDS in Premature Infants
12:00am
8-K
3wx6snotued
30 Jan 06
Other Events
12:00am
8-K
t3e ju6abi9op7p
12 Oct 06
Other Events
12:00am